Mar 31st, 2021, 00:01 | #1 |
Senior Member
注册日期: Jan 2009
帖子: 2,622
|
原來Canada在用印度制造的Covid疫苗
加拿大的50萬劑包括Alberta的5萬多劑AstraZeneca的疫苗(最近血栓疑慮部分叫停的),是印度Covishield制造的,5月還有1百50萬劑要來。 同時在此疫苗上加註警語:注射後如果出現呼吸急促,胸痛,腿部腫脹或持續性腹痛,立即就醫。 問題是為什麼加拿大是七大工業國唯一没有生産疫苗的國家,甚至需要從印度進口? |
|
Mar 31st, 2021, 13:28 | 只看该作者 #2 |
Senior Member
注册日期: Jan 2009
帖子: 2,622
声望: 21733110
|
COVISHIELD
https://healthycanadians.gc.ca/recal...75211a-eng.php AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia Key messages A combination of thrombosis and thrombocytopenia, in some cases accompanied by bleeding, has been observed very rarely following vaccination with the AstraZeneca COVID-19 Vaccine. Health Canada has assessed the available data on the reported events and has determined that the AstraZeneca COVID-19 Vaccine and COVISHIELD (the version of the AstraZeneca COVID-19 Vaccine manufactured by the Serum Institute of India that is currently being distributed in Canada) have not been associated with an increase in the overall risk of thrombosis. Healthcare professionals should be alert to the signs and symptoms of thromboembolism and thrombocytopenia. Individuals vaccinated with AstraZeneca COVID-19 Vaccine or COVISHIELD should be instructed to seek immediate medical attention if they develop symptoms such as shortness of breath, chest pain, leg swelling and persistent abdominal pain following vaccination. Additionally, anyone with neurological symptoms including sudden onset of severe or persistent worsening headaches or blurred vision several days after vaccination, or who experience skin bruising (other than at the site of vaccination) or petechiae starting a few days or more after vaccination, should seek prompt medical attention. Health Canada worked with the manufacturers of AstraZeneca COVID-19 Vaccine and COVISHIELD to update the Product Monographs for these products to include this new safety information. The benefits of the AstraZeneca COVID-19 Vaccine and COVISHIELD in protecting Canadians from COVID-19 continue to outweigh the risks. Canadians are encouraged to get immunized with any of the COVID-19 vaccines that are authorized and available in Canada. Health Canada continues to work closely with international regulators to review data as it becomes available on these very rare events and will make further updates to product labelling or take other actions as needed. |
|